Moreover, a recent study has demonstrated that inhibition of lactate release by blocking monocarboxylate transporter (MCT) 4 promoted anti-tumor immunity of CD8+ T cells in HCC [12]. Here, SLC16A4 is linked to hepatocellular carcinoma.